TY  - JOUR

T1  - Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England

JO  - Applied Health Economics and Health Policy

UR  - https://doi.org/10.1007/s40258-025-00979-4

PY  - 2025/06/02

AU  - Woods B

AU  - Kearns B

AU  - Schmitt L

AU  - Jankovic D

AU  - Rothery C

AU  - Harnan S

AU  - Hamilton J

AU  - Scope A

AU  - Ren S

AU  - Bojke L

AU  - Wilcox M et al

ED  - 

DO  - DOI: 10.1007/s40258-025-00979-4

PB  - Springer Science and Business Media LLC

Y2  - 2025/06/10

ER  -